DNY-29083-74853
4 vaccinations
3 coded responses
51 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 948 / CA
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Pfizer-BioNTech
- 2021-03-31
-
2021-04-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-14
- 2021-04-21
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body achesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-05-02
- 2021-05-12
- 2021-05-19
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-07-27
-
2021-11-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-11-04
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling · Fatigue or tirednessAdult check-in
-
2021-11-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-10
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
- 2022-02-03
- 2022-05-05
-
2022-05-16
Dose 4 — Moderna
-
2022-05-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-18
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body achesAdult check-in
- 2022-05-20
- 2022-05-21
- 2022-05-22
- 2022-05-23
- 2022-05-30
- 2022-06-06
- 2022-06-13
- 2022-06-20
-
2022-06-27
Survey response — day 42, dose 4MedDRA: Biochemical pregnancy — Feeling: GoodFree text: Chemical pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-08-18
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-08-18
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-19
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-18
- 2023-05-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Pfizer-BioNTech | Flu |
| 4 | 2022-05-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-18 | Successful 2022-08-19 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes
Release 12 — day 42, dose 4
Symptoms: Chemical pregnancy
Release 12 — 3 months, dose 4
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Biochemical pregnancy | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release